B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge. - Wikidata - awgldk - TriplyDB

B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.

B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.

http://www.wikidata.org/entity/Q37396545

about

Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.Expression of ICAM-1, HLA-DR, and CD80 on peripheral circulating CD1 alpha DCs induced in vivo by IFN-alpha in patients with chronic hepatitis B Cross-linking of CD80 and CD86 Diminishes Expression of CD54 on EBV-transformed B Cells through Inactivation of RhoA and Ras CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells Ovarian cancer vaccine trials and tribulations.The T cell activation molecule H4 and the CD28-like molecule ICOS are identical.B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8+ Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy.

P2860

Q34002747-A23F4015-A0D4-4634-B84C-F8D69716A796 Q34012742-90D72E63-AE5D-48EC-9E6C-9A458BCD3CCD Q34162351-FBD8B53F-E4B4-4C14-9952-7690DD6534F8 Q35024341-80C3C3B0-03C0-4601-BB5F-871139DE209D Q35405162-7041727B-608F-442D-B3F4-EC310F9FCE20 Q36675457-F3F72056-4F75-400D-AB80-FC1765759C11 Q40840282-3D909239-83A4-454B-B020-2E206F451390 Q45868892-26DEB8F9-19F1-4AE6-801D-0F620DF71A8C Q47223979-5A4D958C-AC03-4A3B-9A77-99BDF7F00F44

P2860

B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.

http://www.wikidata.org/entity/Q37396545

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 1998

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

B7-CTLA4 interaction enhances ...... resistance to tumor challenge.

@en

B7-CTLA4 interaction enhances ...... resistance to tumor challenge.

@nl

type

label

B7-CTLA4 interaction enhances ...... resistance to tumor challenge.

@en

B7-CTLA4 interaction enhances ...... resistance to tumor challenge.

@nl

prefLabel

B7-CTLA4 interaction enhances ...... resistance to tumor challenge.

@en

B7-CTLA4 interaction enhances ...... resistance to tumor challenge.

@nl

P1433

Q37396545-0D02A3BF-0CDF-4776-B4B7-F3027B71BCD6

P1476

Q37396545-7FADE0FD-B00C-4518-BB1D-BED7EDC66A6A

P2093

Q37396545-0CBBDE60-9F10-4607-9FA9-25C6220D4315

Q37396545-3CFE0E2D-2F7D-477E-A127-1F257B06017D

Q37396545-E4BA174C-9ADB-4966-A0FD-554649512D8F

P2860

Q37396545-0725FD40-4912-445A-B39C-9EB48C5DD12A

Q37396545-08042F87-7F05-4890-A678-0FF52C53DE0B

Q37396545-0A8ED234-7163-4EB1-A0C4-40A503298806

Q37396545-0FD07581-A198-4BC9-94D3-1122D4CE6BD6

Q37396545-2D015412-81E0-48EA-99AD-3AF11B4F05F2

Q37396545-34198FF2-0833-4607-882A-AB2F2D49B053

Q37396545-34D11F64-6D06-4820-8525-F71B4A4D3C1F

Q37396545-5ECCEFBF-955C-4640-B3B2-773E8894A44E

Q37396545-63A11CDC-C2B1-4203-8C99-8EF2BCAA3F21

Q37396545-6B7F75CA-EE4A-4D37-9036-CA70F9FBE5BC

P304

Q37396545-25643A3F-B1BA-40FA-9875-C84F4EFBD55C

P31

Q37396545-010A1780-E2AD-4172-B148-8D9D40225A6F

P356

Q37396545-6F1DAC24-341F-4E17-82E1-8A99256CC349

P407

Q37396545-32C64875-44FE-44BA-B7F5-A632ECA744D4

P433

Q37396545-B56308E4-E53D-4614-9E07-CA5CC3E3DBDB

P478

Q37396545-FF53726F-DA93-4B56-AD3F-614CEBEE1B2B

P50

Q37396545-62909280-2ECA-42B3-9972-F0B771E026B6

Q37396545-D1BE6798-5EE2-4E9C-A02D-D01783140E46

P577

Q37396545-140C39AB-7A94-4EAB-9AF3-72F0B7B6CBBF

P5875

Q37396545-37176241-C7FC-496E-B9FD-5B21131FBFB1

P698

Q37396545-80310BE7-0ED5-42F3-8586-FA7B8DEFA8FF

P921

Q37396545-EE8FFBA5-FBC1-4B9A-B800-A4DCDBDCA535

P932

Q37396545-40230B0A-3EFE-424E-85B6-7494089A509E

P356

PNAS.95.11.6284

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

B7-CTLA4 interaction enhances ...... resistance to tumor challenge

@en

P2093

C Lee

http://www.w3.org/2001/XMLSchema#string

Y Guo

http://www.w3.org/2001/XMLSchema#string

Y Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen)

Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex

CTLA-4 ligation blocks CD28-dependent T cell activation

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

CTLA-4 can function as a negative regulator of T cell activation

Enhancement of antitumor immunity by CTLA-4 blockade

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

Heat-stable antigen is a costimulatory molecule for CD4 T cell growth

Differential T cell costimulatory requirements in CD28-deficient mice

P304

6284-6289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.11.6284

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

P577

1998-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24458241

http://www.w3.org/2001/XMLSchema#string

P698

9600957

http://www.w3.org/2001/XMLSchema#string

P921

P932

27659

http://www.w3.org/2001/XMLSchema#string